LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM)

Metadata

Authors/Creators:	Vasudev, NS https://orcid.org/0000-0001-8470-7481 Ainsworth, G Brown, S https://orcid.org/0000-0002-7975-7537 Pickering, L Waddell, TS Fife, K Griffiths, R Sharma, A Katona, E Howard, H Velikova, G https://orcid.org/0000-0003-1899-5942 Maraveyas, A Brown, JE Venugopal, B Patel, P Jain, A Symeonides, S Nathan, PD Collinson, F Powles, TB
Dates:	Published: 2021
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	10 Dec 2021 16:01
Last Modified:	10 Dec 2021 16:01
Status:	Published
Identification Number:	https://doi.org/10.1016/j.annonc.2021.08.2105
Related URLs:	Author

CORE (COnnecting REpositories)